Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases.
No significant events in the past 90 days.
—
Market Cap
—
Revenue
—
Net Income
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
No significant events in the past 90 days.